NEWS & EVENTS

20.10.2008 - Kuopio, Finland

Medeia Therapeutics announces the second financing round led by Inveni Capital
Read More...

29.07.2008 - Kuopio, Finland

Medeia Therapeutics reports new data on bone marrow
Read More...

05.11.2007 - Kuopio, Finland

Medeia Therapeutics participates in research on beta-amyloid peptide clearance
Read More...

19.06.2007 - Kuopio, Finland

Medeia Therapeutics Ltd and Orion Corporation sign a research and option agreement
Read More...

19.03.2007 - Kuopio, Finland

Medeia Therapeutics Co-Authors Seminal Findings on Mechanisms of Neurodegeneration in the latest issue of Nature Neuroscience
Read More...

Welcome to Medeia Therapeutics Ltd.

Medeia Therapeutics Ltd. is an emerging drug discovery company dedicated to discover and develop new therapeutic approaches for diseases with high unmet clinical needs.

Our discovery platforms aim at developing therapeutics for neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Amyotrophic lateral sclerosis, Spinal cord injury and Stroke.

The mission of Medeia Therapeutics is to discover and develop new therapeutics to combat neurodegeneration.